Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (141-150 of 205) with videos related to

Pageof 21
Sort By:
Journal of Hepatology|March 9, 2018
Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinomaJulia Chalaye, Charlotte E Costentin, Alain Luciani, et al.
World Journal of Hepatology|April 5, 2013
Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatientsJean-François Cadranel, Jean-Baptiste Nousbaum, Christophe Bessaguet, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2024
Upfront multi-bipolar radiofrequency ablation for HCC in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrenceCarina Boros, Olivier Sutter, François Cauchy, et al.
Clinics and Research in Hepatology and Gastroenterology|April 15, 2023
Individual and population screening of varices needing treatment by a simple, safe and accurate testFederico Ravaioli, Arthur Berger, Oana Farcau, et al.
Hepatology (Baltimore, Md.)|April 12, 2018
Influence of Progenitor-Derived Regeneration Markers on Hepatitis C Virus-Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort)Dominique Wendum, Richard Layese, Nathalie Ganne-Carrié, et al.
Gut|July 25, 2024
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatmentsClaudia Campani, Sandrine Imbeaud, Gabrielle Couchy, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2025
A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY DataHéloïse Bourien, Xavier Adhoute, Boris Campillo-Gimenez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 28, 2018
Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC CohortMoana Gelu-Simeon, Maïté Lewin, Maria Ostos, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinomaLorraine Blaise, Marianne Ziol, Claudia Campani, et al.
Oncoimmunology|August 16, 2019
Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinomaPhilippe Rochigneux, Jean-Charles Nault, Françoise Mallet, et al.
Pageof 21

Showing results (141-150 of 205) with videos related to

Sort By:
Pageof 21
Journal of Hepatology|March 9, 2018
Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinomaJulia Chalaye, Charlotte E Costentin, Alain Luciani, et al.
World Journal of Hepatology|April 5, 2013
Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatientsJean-François Cadranel, Jean-Baptiste Nousbaum, Christophe Bessaguet, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2024
Upfront multi-bipolar radiofrequency ablation for HCC in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrenceCarina Boros, Olivier Sutter, François Cauchy, et al.
Clinics and Research in Hepatology and Gastroenterology|April 15, 2023
Individual and population screening of varices needing treatment by a simple, safe and accurate testFederico Ravaioli, Arthur Berger, Oana Farcau, et al.
Hepatology (Baltimore, Md.)|April 12, 2018
Influence of Progenitor-Derived Regeneration Markers on Hepatitis C Virus-Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort)Dominique Wendum, Richard Layese, Nathalie Ganne-Carrié, et al.
Gut|July 25, 2024
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatmentsClaudia Campani, Sandrine Imbeaud, Gabrielle Couchy, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2025
A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY DataHéloïse Bourien, Xavier Adhoute, Boris Campillo-Gimenez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 28, 2018
Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC CohortMoana Gelu-Simeon, Maïté Lewin, Maria Ostos, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinomaLorraine Blaise, Marianne Ziol, Claudia Campani, et al.
Oncoimmunology|August 16, 2019
Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinomaPhilippe Rochigneux, Jean-Charles Nault, Françoise Mallet, et al.
Pageof 21